Relative Bioavailability of a Single Dose of BI 44370 Tablet During and Between Migraine Attacks
Clinical trial NCT00743015 · COMPLETED
Trial details
- NCT number
- NCT00743015
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2009-03-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.